L'BEL DIVINE Double Use Compact SPF 15 gold deluxe edition

Double Use Compact SPF 15 gold deluxe edition Medium 7 by

Drug Labeling and Warnings

Double Use Compact SPF 15 gold deluxe edition Medium 7 by is a Otc medication manufactured, distributed, or labeled by Ventura International LTD, Bel Star S.A. (Colombia). Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION CLAIRE 1-2-3- octinoxate, titanium dioxide, zinc oxide powder 
DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION CLAIRE 4- octinoxate, titanium dioxide, zinc oxide powder 
DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION MEDIUM 5- octinoxate, titanium dioxide, zinc oxide powder 
DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION MEDIUM 6- octinoxate, titanium dioxide, zinc oxide powder 
DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION MEDIUM 7- octinoxate, titanium dioxide, zinc oxide powder 
Ventura International LTD

----------

L'BEL DIVINE Double Use Compact SPF 15 gold deluxe edition

Active ingredients Purpose

Octinoxate 3.00% Sunscreen

Titanium Dioxide 6.24% Sunscreen

Zinc Oxide 4.90 % Sunscreen

Uses:

Helps prevent Sunburn

• Keep out of reach of children.If swallowed, get medical help, or contact a Poison Control Center right away.

Stop use and ask a doctor ifrash occurs.

Warnings:Skin Cancer / Skin Aging Alert:Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to prevent sunburn, notskin cancer or early skin aging.

• For external use only
• Do not useon damaged or broken skin
• When using this product,keep out of eyes. Rinse with water to remove.

Directions:

• Apply liberally and evenly 15 minutes before sun exposure.
• Reapply at least every 2 hours
• Use a water resistant sunscreen if swimming or sweating
• Children under 6 months of age: Ask a doctor

Other information:

• Protect the product in this container from excessive heat and direct sun

Inactive ingredients:Mica, polymethylsilsesquioxane, hdi/trimethylol hexyllactone crosspolymer, dimethicone, magnesium stearate, trimethylsiloxysilicate, isostearyl neopentanoate, hydrogen dimethicone, tocopheryl acetate, phenoxyethanol, alumina, triethoxycaprylylsilane, fragrance, caprylyl glycol, ceramide np, chlorphenesin, butylphenyl methylpropional, hydroxycitronellal, citronellol, geraniol, limonene, alpha-isomethyl ionone, May contain:Iron oxides, titanium dioxide

L'BEL

Divine

Polvos Compactos doble uso FPS 15 edicion de lujo dorado

Double use compact SPF 15 gold deluxe edition

Tone: Claire 1-2-3

Net. Wt. 0.35 oz (10g)

L'BEL

Divine

Polvos Compactos doble uso FPS 15 edicion de lujo dorado

Double use compact SPF 15 gold deluxe edition

Tone: Claire 4

Net. Wt. 0.35 oz (10g)

L'BEL

Divine

Polvos Compactos doble uso FPS 15 edicion de lujo dorado

Double use compact SPF 15 gold deluxe edition

Tone: Medium 5

Net. Wt. 0.35 oz (10g)

L'BEL

Divine

Polvos Compactos doble uso FPS 15 edicion de lujo dorado

Double use compact SPF 15 gold deluxe edition

Tone: Medium 6

Net. Wt. 0.35 oz (10g)

L'BEL

Divine

Polvos Compactos doble uso FPS 15 edicion de lujo dorado

Double use compact SPF 15 gold deluxe edition

Tone: Medium 7

Net. Wt. 0.35 oz (10g)

DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION CLAIRE 1-2-3 
octinoxate, titanium dioxide, zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 14783-275
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	4.9 g  in 100 g
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	6.24 g  in 100 g
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	3 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
CHLORPHENESIN (UNII: I670DAL4SZ)
ISOMETHYL-.ALPHA.-IONONE (UNII: 9XP4LC555B)
CERAMIDE NP (UNII: 4370DF050B)
BUTYLPHENYL METHYLPROPIONAL (UNII: T7540GJV69)
GERANIOL (UNII: L837108USY)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
ISOSTEARYL NEOPENTANOATE (UNII: 411THY156Q)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER (UNII: WB5K9Y35Y9)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERRIC OXIDE RED (UNII: 1K09F3G675)
POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)
DIMETHICONE (UNII: 92RU3N3Y1O)
MAGNESIUM STEARATE (UNII: 70097M6I30)
HYDROXYCITRONELLAL (UNII: 8SQ0VA4YUR)
MICA (UNII: V8A1AW0880)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
.BETA.-CITRONELLOL, (R)- (UNII: P01OUT964K)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)
ALUMINUM OXIDE (UNII: LMI26O6933)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 14783-275-01	10 g in 1 BOTTLE; Type 0: Not a Combination Product	11/12/2020	12/31/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	11/12/2020	12/31/2021

DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION CLAIRE 4 
octinoxate, titanium dioxide, zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 14783-276
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	4.9 g  in 100 g
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	6.24 g  in 100 g
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	3 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
CHLORPHENESIN (UNII: I670DAL4SZ)
ISOMETHYL-.ALPHA.-IONONE (UNII: 9XP4LC555B)
CERAMIDE NP (UNII: 4370DF050B)
BUTYLPHENYL METHYLPROPIONAL (UNII: T7540GJV69)
GERANIOL (UNII: L837108USY)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
ISOSTEARYL NEOPENTANOATE (UNII: 411THY156Q)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER (UNII: WB5K9Y35Y9)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERRIC OXIDE RED (UNII: 1K09F3G675)
POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)
DIMETHICONE (UNII: 92RU3N3Y1O)
MAGNESIUM STEARATE (UNII: 70097M6I30)
HYDROXYCITRONELLAL (UNII: 8SQ0VA4YUR)
MICA (UNII: V8A1AW0880)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
.BETA.-CITRONELLOL, (R)- (UNII: P01OUT964K)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)
ALUMINUM OXIDE (UNII: LMI26O6933)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 14783-276-01	10 g in 1 BOTTLE; Type 0: Not a Combination Product	11/12/2020	12/31/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	11/12/2020	12/31/2021

DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION MEDIUM 5 
octinoxate, titanium dioxide, zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 14783-277
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	4.9 g  in 100 g
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	6.24 g  in 100 g
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	3 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
CHLORPHENESIN (UNII: I670DAL4SZ)
ISOMETHYL-.ALPHA.-IONONE (UNII: 9XP4LC555B)
CERAMIDE NP (UNII: 4370DF050B)
BUTYLPHENYL METHYLPROPIONAL (UNII: T7540GJV69)
GERANIOL (UNII: L837108USY)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
ISOSTEARYL NEOPENTANOATE (UNII: 411THY156Q)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER (UNII: WB5K9Y35Y9)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERRIC OXIDE RED (UNII: 1K09F3G675)
POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)
DIMETHICONE (UNII: 92RU3N3Y1O)
MAGNESIUM STEARATE (UNII: 70097M6I30)
HYDROXYCITRONELLAL (UNII: 8SQ0VA4YUR)
MICA (UNII: V8A1AW0880)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
.BETA.-CITRONELLOL, (R)- (UNII: P01OUT964K)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)
ALUMINUM OXIDE (UNII: LMI26O6933)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 14783-277-01	10 g in 1 BOTTLE; Type 0: Not a Combination Product	11/12/2020	12/31/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	11/12/2020	12/31/2021

DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION MEDIUM 6 
octinoxate, titanium dioxide, zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 14783-278
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	4.9 g  in 100 g
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	6.24 g  in 100 g
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	3 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
CHLORPHENESIN (UNII: I670DAL4SZ)
ISOMETHYL-.ALPHA.-IONONE (UNII: 9XP4LC555B)
CERAMIDE NP (UNII: 4370DF050B)
BUTYLPHENYL METHYLPROPIONAL (UNII: T7540GJV69)
GERANIOL (UNII: L837108USY)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
ISOSTEARYL NEOPENTANOATE (UNII: 411THY156Q)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER (UNII: WB5K9Y35Y9)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERRIC OXIDE RED (UNII: 1K09F3G675)
POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)
DIMETHICONE (UNII: 92RU3N3Y1O)
MAGNESIUM STEARATE (UNII: 70097M6I30)
HYDROXYCITRONELLAL (UNII: 8SQ0VA4YUR)
MICA (UNII: V8A1AW0880)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
.BETA.-CITRONELLOL, (R)- (UNII: P01OUT964K)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)
ALUMINUM OXIDE (UNII: LMI26O6933)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 14783-278-01	10 g in 1 BOTTLE; Type 0: Not a Combination Product	11/12/2020	12/31/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	11/12/2020	12/31/2021

DOUBLE USE COMPACT SPF 15 GOLD DELUXE EDITION MEDIUM 7 
octinoxate, titanium dioxide, zinc oxide powder

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 14783-279
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	4.9 g  in 100 g
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	6.24 g  in 100 g
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	3 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
CHLORPHENESIN (UNII: I670DAL4SZ)
ISOMETHYL-.ALPHA.-IONONE (UNII: 9XP4LC555B)
CERAMIDE NP (UNII: 4370DF050B)
BUTYLPHENYL METHYLPROPIONAL (UNII: T7540GJV69)
GERANIOL (UNII: L837108USY)
ALUMINUM OXIDE (UNII: LMI26O6933)
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)
ISOSTEARYL NEOPENTANOATE (UNII: 411THY156Q)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER (UNII: WB5K9Y35Y9)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
FERRIC OXIDE RED (UNII: 1K09F3G675)
POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)
DIMETHICONE (UNII: 92RU3N3Y1O)
MAGNESIUM STEARATE (UNII: 70097M6I30)
HYDROXYCITRONELLAL (UNII: 8SQ0VA4YUR)
MICA (UNII: V8A1AW0880)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
.BETA.-CITRONELLOL, (R)- (UNII: P01OUT964K)
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 14783-279-01	10 g in 1 BOTTLE; Type 0: Not a Combination Product	11/12/2020	12/31/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	11/12/2020	12/31/2021

Labeler - Ventura International LTD (603192787)

Establishment
Name	Address	ID/FEI	Business Operations
Bel Star S.A. (Colombia)		880160197	manufacture(14783-279, 14783-275, 14783-276, 14783-277, 14783-278)

Revised: 3/2025

Document Id: 2f75d108-d159-30ad-e063-6394a90a4203

34390-5

Set id: b5f80ba2-c0b2-5349-e053-2a95a90ae1c5

Version: 3

Effective Time: 20250303